Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Akihiro Hirakawa, Masahiko Ando, Masahiro Hayakawa, Nao Matsuyama, Shinobu Shimizu, Kazuto Ueda, Toshihiko Suzuki, Sakiko Suzuki, Ryosuke Miura, Akemi Katayama, Masaaki Mizuno, Yoshiaki Sato
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2022-04-01
Seri Bilgileri:BMJ Open
Online Erişim:https://bmjopen.bmj.com/content/12/4/e057073.full
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller